Abstract
We report the first case of malignant hyperthermia from the Indian sub-continent and raise the issue of non-availability of dantrolene in a country, where this clinical entity was thought not to exist.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have